AR097997A1 - Composición farmaceutica de ibuprofeno y tramadol para uso oftálmico - Google Patents
Composición farmaceutica de ibuprofeno y tramadol para uso oftálmicoInfo
- Publication number
- AR097997A1 AR097997A1 ARP140103790A ARP140103790A AR097997A1 AR 097997 A1 AR097997 A1 AR 097997A1 AR P140103790 A ARP140103790 A AR P140103790A AR P140103790 A ARP140103790 A AR P140103790A AR 097997 A1 AR097997 A1 AR 097997A1
- Authority
- AR
- Argentina
- Prior art keywords
- tramadol
- ibuprofen
- pharmaceutical composition
- concentration
- ophthalmic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Se refiere a una composición farmacéutica de ibuprofeno y tramadol para uso oftálmico. Dicha composición resulta para el tratamiento de la inflamación y/o el dolor ocular asociados a diversas enfermedades o estados patológicos que afectan a la zona ocular. En particular, la composición oftálmica está indicada, por ejemplo, para el tratamiento del dolor y/o la inflamación tras cirugía ocular. Reivindicación 1: Composición farmacéutica oftálmica acuosa que comprende: a) ibuprofeno, o una sal farmacéuticamente aceptable del mismo, en una concentración comprendida entre 0,01% (p/v) y 0,5% (p/v); y b) tramadol, o una sal farmacéuticamente aceptable del mismo, en una concentración, expresada como concentración equivalente de hidrocloruro de tramadol, comprendida entre 0,05% (p/v) y 2% (p/v).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201300963A ES2540151B1 (es) | 2013-10-11 | 2013-10-11 | Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR097997A1 true AR097997A1 (es) | 2016-04-27 |
Family
ID=51868157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140103790A AR097997A1 (es) | 2013-10-11 | 2014-10-10 | Composición farmaceutica de ibuprofeno y tramadol para uso oftálmico |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10292953B2 (es) |
| EP (1) | EP2862565B1 (es) |
| AR (1) | AR097997A1 (es) |
| BR (1) | BR102014025307B1 (es) |
| CY (1) | CY1120642T1 (es) |
| DK (1) | DK2862565T3 (es) |
| ES (2) | ES2540151B1 (es) |
| HR (1) | HRP20181282T1 (es) |
| HU (1) | HUE040093T2 (es) |
| MX (1) | MX355770B (es) |
| PL (1) | PL2862565T3 (es) |
| PT (1) | PT2862565T (es) |
| RU (1) | RU2694369C2 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITUB20153104A1 (it) * | 2015-08-13 | 2017-02-13 | Sooft Italia S P A Contrada Molino 17 68333 Montegiorgio Fm | Composizione ed uso di collirio a base di inositolo per migliorare l'accomodazione visiva dei pazienti |
| ES2604816B1 (es) * | 2015-09-09 | 2018-01-29 | Farmalider, S.A. | Composición farmacéutica de tramadol para uso oftálmico |
| AR102172A1 (es) | 2015-10-05 | 2017-02-08 | Química Luar S R L | Una composición farmacéutica bactericida y virucida |
| RU2624901C2 (ru) * | 2015-10-05 | 2017-07-07 | Елизавета Геннадьевна Полунина | Средство для аппликационной анестезии с антисептическими, оптикокератопротективными свойствами и способ его применения в офтальмологии |
| CN110475543B (zh) | 2016-09-30 | 2023-07-25 | 马缇医疗股份有限公司 | 眼用药物持续释放制剂及其用途 |
| ES2952013T3 (es) * | 2019-07-09 | 2023-10-26 | Farmalider Sa | Combinación de ibuprofeno y tramadol para aliviar el dolor |
| US12324853B2 (en) | 2020-08-10 | 2025-06-10 | Quimica Luar S.R.L. | Methods for treating respiratory viral infections |
| TW202408467A (zh) * | 2022-07-06 | 2024-03-01 | 日商樂敦製藥股份有限公司 | 眼科組成物 |
| WO2025159099A1 (ja) * | 2024-01-24 | 2025-07-31 | 国立大学法人北海道大学 | 医薬組成物、眼瞼けいれん処置薬、知覚過敏またはジストニア処置薬、および症状モデルマウス |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB971700A (en) | 1961-02-02 | 1964-09-30 | Boots Pure Drug Co Ltd | Anti-Inflammatory Agents |
| US3652589A (en) | 1967-07-27 | 1972-03-28 | Gruenenthal Chemie | 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols |
| GB1497044A (en) | 1974-03-07 | 1978-01-05 | Prodotti Antibiotici Spa | Salts of phenyl-alkanoic acids |
| AU661723B2 (en) * | 1991-10-30 | 1995-08-03 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
| US20040224010A1 (en) * | 2002-11-15 | 2004-11-11 | Optime Therapeutics, Inc. | Ophthalmic liposome compositions and uses thereof |
| MY135852A (en) * | 2003-04-21 | 2008-07-31 | Euro Celtique Sa | Pharmaceutical products |
| CN1513442A (zh) * | 2003-06-26 | 2004-07-21 | 昆明市延安医院 | 精氨酸-布洛芬混合物的制法和用途 |
| CA2608631C (en) * | 2005-06-09 | 2014-07-29 | Biolipox Ab | Method and composition for treating inflammatory disorders |
| MX2009004203A (es) * | 2006-10-20 | 2009-07-02 | Mcneil Ppc Inc | Combinaciones de paracetamol/ibuprofeno y metodo para su uso. |
| US20080275131A1 (en) * | 2007-04-30 | 2008-11-06 | Adolor Corporation | Compositions of (-)-e-10-oh-nt and methods for their synthesis and use |
| ES2356762B1 (es) * | 2009-09-04 | 2011-11-24 | Farmalider S.A. | Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma. |
| CN102058581B (zh) * | 2010-11-30 | 2013-01-30 | 广东宏盈科技有限公司 | 一种眼用凝胶 |
| JP6148664B2 (ja) * | 2011-04-05 | 2017-06-14 | オプトソルヴ リサーチ アンド ディベロップメント リミテッド | 眼科治療 |
| ES2423866B1 (es) * | 2012-02-22 | 2014-06-10 | Farmalider, S.A. | Composición farmaceútica de ibuprofeno y tramadol para inyección |
| GB201217522D0 (en) * | 2012-10-01 | 2012-11-14 | Sharma Anant | ophthalmic therapy |
-
2013
- 2013-10-11 ES ES201300963A patent/ES2540151B1/es active Active
-
2014
- 2014-10-08 MX MX2014012158A patent/MX355770B/es active IP Right Grant
- 2014-10-10 PL PL14380031T patent/PL2862565T3/pl unknown
- 2014-10-10 PT PT14380031T patent/PT2862565T/pt unknown
- 2014-10-10 HU HUE14380031A patent/HUE040093T2/hu unknown
- 2014-10-10 EP EP14380031.6A patent/EP2862565B1/en active Active
- 2014-10-10 RU RU2014140885A patent/RU2694369C2/ru active
- 2014-10-10 ES ES14380031.6T patent/ES2685023T3/es active Active
- 2014-10-10 DK DK14380031.6T patent/DK2862565T3/en active
- 2014-10-10 AR ARP140103790A patent/AR097997A1/es not_active Application Discontinuation
- 2014-10-10 US US14/511,321 patent/US10292953B2/en active Active
- 2014-10-10 BR BR102014025307-6A patent/BR102014025307B1/pt active IP Right Grant
-
2018
- 2018-08-03 HR HRP20181282TT patent/HRP20181282T1/hr unknown
- 2018-08-17 CY CY181100867T patent/CY1120642T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US10292953B2 (en) | 2019-05-21 |
| EP2862565B1 (en) | 2018-05-23 |
| MX2014012158A (es) | 2015-05-27 |
| EP2862565A1 (en) | 2015-04-22 |
| US20150105468A1 (en) | 2015-04-16 |
| PL2862565T3 (pl) | 2018-10-31 |
| CY1120642T1 (el) | 2019-12-11 |
| HRP20181282T1 (hr) | 2018-10-05 |
| ES2685023T3 (es) | 2018-10-05 |
| DK2862565T3 (en) | 2018-08-13 |
| BR102014025307A2 (pt) | 2015-09-29 |
| MX355770B (es) | 2018-04-30 |
| RU2014140885A3 (es) | 2018-06-14 |
| ES2540151B1 (es) | 2016-02-29 |
| ES2540151A1 (es) | 2015-07-08 |
| PT2862565T (pt) | 2018-10-16 |
| BR102014025307B1 (pt) | 2021-11-03 |
| RU2014140885A (ru) | 2016-04-27 |
| RU2694369C2 (ru) | 2019-07-12 |
| HUE040093T2 (hu) | 2019-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR097997A1 (es) | Composición farmaceutica de ibuprofeno y tramadol para uso oftálmico | |
| CL2017002527A1 (es) | Uso de agonistas de receptor de péptido formilo 2 para tratar enfermedades inflamatorias oculares. (divisional de solicitud n°2485-2015). | |
| AR121843A2 (es) | Formulación oftálmica y método para mejorar la presbicia | |
| NI201700101A (es) | Composiciones farmacéuticas que comprenden n - (3, 5 - dimetoxifenil) - n'- (1-metiletil) - n - [3-(1-metil-1h-pirazol-4-il) quinoxalina-6-il]etano-1,2-diamina | |
| CL2015002941A1 (es) | Usos terapéuticos de empaglifozina | |
| CL2018001089A1 (es) | Sales de valbenazina y polimorfos de las mismas. | |
| CL2012001583A1 (es) | Preparación oftálmica que comprende: a) povidona yodada, b) un agente refrescante y c) uno o más entre alcanfor, borneol, lubricante, emoliente, antiinflamatorio esteroidal y antinflamatorio no esteroidal; y su uso para el tratamiento y/o profilaxis de un trastorno ocular o una infección. | |
| CR20150628A (es) | Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades | |
| MX2018013472A (es) | Tratamiento de combinacion de trastornos y enfermedades inflamatorios oculares. | |
| CL2010001406A1 (es) | Composicion farmaceutica oftalmica que comprende povidona yodada, y un compuesto antiinflamatorio esteroidal, un compuesto antiinflamatorio no esteroidal, un antibacteriano, un antialergico o un compuesto antiglaucoma; y metodo para preservar la composicion. | |
| MX2022010774A (es) | Composiciones que comprenden aminoacidos para su uso en el tratamiento de enfermedades relacionadas con la disfuncion mitocondrial. | |
| CL2009001077A1 (es) | Vehiculo particulado polimerico que comprende un agente biologico en fase acuosa en un lumen hueco; procedimiento para suministrar una proteina en el ojo; composicion farmaceutica que comprende dicho vehiculo; y su uso para profilaxis y tratar enfermedades o trastornos del ojo. | |
| PE20160012A1 (es) | Tratamiento de enfermedades miopaticas y neurogenerativas por agregacion de proteina mediante administracion parenteral | |
| AR088585A1 (es) | Un medicamento para tratar la enfermedad del ojo anterior | |
| MX2019009190A (es) | Uso de gaboxadol en el tratamiento de tinnitus. | |
| AR097619A1 (es) | Uso de inhibidores de acetil-coa carboxilasa para tratar acné vulgaris | |
| EA201692402A1 (ru) | Лекарственные формы для местного применения и их использование | |
| MX2019001850A (es) | Formulaciones para administracion oral de principios activos. | |
| AR103415A1 (es) | Tratamiento de pacientes pediátricos con diabetes mellitus de tipo 2 | |
| ES2609817T3 (es) | Leucotoxina E/D como nuevo agente antiinflamatorio y microbicida | |
| UY33153A (es) | Formulación tópica oftálmica de péptidos | |
| CL2015002627A1 (es) | Composiciones para el uso en el tratamiento de trastornos oculares que usan dipiridamol | |
| MX2017015293A (es) | Composicion para tratar lesiones tisulares. | |
| AR098832A1 (es) | Uso de laquinimod para retrasar la progresión de la enfermedad de huntington | |
| MX2018002298A (es) | Metodos de uso de interleucina 10 para el tratamiento de enfermedades y trastornos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |